Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Summary of Significant Accounting and Reporting Policies - Schedule of Dilutive Securities Excluded from Computation (Details)

v3.21.1
Nature of Operations and Summary of Significant Accounting and Reporting Policies - Schedule of Dilutive Securities Excluded from Computation (Details) - shares
9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Antidilutive securities excluded from computation of earnings per share 3,666,002 106,216
Stock Options [Member]    
Antidilutive securities excluded from computation of earnings per share 60 60
Stock Warrants [Member]    
Antidilutive securities excluded from computation of earnings per share 127,595 1,975
Unvested Restricted Stock [Member]    
Antidilutive securities excluded from computation of earnings per share 59 117
Convertible Debt [Member]    
Antidilutive securities excluded from computation of earnings per share 3,538,288 104,064